Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 146
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
BMC Health Serv Res ; 23(1): 423, 2023 May 02.
Artigo em Inglês | MEDLINE | ID: mdl-37131261

RESUMO

BACKGROUND: While many healthcare providers (HCPs) have navigated patients' vaccine concerns and questions prior to the rollout of the COVID-19 vaccines, sentiments surrounding the COVID-19 vaccines have presented new and distinct challenges. OBJECTIVE: To understand the provider experience of counseling patients about COVID-19 vaccinations, aspects of the pandemic environment that impacted vaccine trust, and communication strategies providers found supportive of patient vaccine education. METHODS: 7 focus groups of healthcare providers were conducted and recorded during December 2021 and January 2022, at the height of the Omicron wave in the United States. Recordings were transcribed, and iterative coding and analysis was applied. RESULTS: 44 focus group participants representing 24 US states with the majority (80%) fully vaccinated at the time of data collection. Most participants were doctors (34%) or physician's assistants and nurse practitioners (34%). The negative impact of COVID-19 misinformation on patient-provider communication at both intrapersonal and interpersonal levels as well as barriers and facilitators to patient vaccine uptake are reported. People or sources that play a role in health communication ("messengers") and persuasive messages that impact behavior or attitudes towards vaccination ("messages") are described. Providers expressed frustration in the need to continuously address vaccine misinformation in clinical appointments among patients who remained unvaccinated. Many providers found value in resources that provided up-to-date and evidence-based information as COVID-19 guidelines continued to change. Additionally, providers indicated that patient-facing materials designed to support vaccination education were not frequently available, but they were the most valuable to providers in a changing information environment. CONCLUSIONS: While vaccine decision-making is complex and hinges on diverse factors such as health care access (i.e., convenience, expense) and individual knowledge, providers can play a major role in navigating these factors with their patients. But to strengthen provider vaccine communication and promote vaccine uptake, a comprehensive communication infrastructure must be sustained to support the patient-provider dyad. The findings provide recommendations to maintain an environment that facilitates effective provider-patient communication at the community, organizational and policy levels. There is a need for a unified multisectoral response to reinforce the recommendations in patient settings.


Assuntos
COVID-19 , Comunicação em Saúde , Vacinas , Humanos , Estados Unidos , Vacinas contra COVID-19 , COVID-19/epidemiologia , COVID-19/prevenção & controle , Comunicação , Pessoal de Saúde/psicologia , Vacinação/psicologia
2.
J Health Commun ; 28(sup1): 54-66, 2023 Apr 07.
Artigo em Inglês | MEDLINE | ID: mdl-37390010

RESUMO

Although public and private institutions have spent billions of dollars on COVID-19 vaccination campaigns, many of which claim to be "equity-focused," few articles to date have objectively described the landscape of these campaigns or identified existing gaps with a focus on those populations disproportionately impacted by the virus. To these ends, a high-level landscape analysis of COVID-related communication campaigns was conducted. Analysis of 15 COVID-related communication campaigns based on six criteria (i.e., understandability, accessibility, actionability, credibility/trustworthiness, relevance/relatability, and timeliness) identified successful efforts, including campaigns aligned with the World Health Organization's Strategic Communications Framework and rooted in community co-design and communication science. The analysis also revealed five common shortcomings: campaigns were not end-user focused, only "checked the box" when communicating with historically under-resourced communities, were largely broadcast-focused and rarely involved two-way engagement strategies or tactics, demonstrated poor use of online communication approaches and failed to moderate campaign comment boards/social media sites, and commonly targeted "intermediary" audiences with materials that were not "end user ready." Based on these findings, the authors offer recommendations to guide funding and development of future health communication campaigns focused on reaching diverse audiences.


Assuntos
COVID-19 , Comunicação em Saúde , Humanos , Saúde Pública , Vacinas contra COVID-19/uso terapêutico , COVID-19/prevenção & controle , Vacinação
3.
J Health Commun ; 28(sup1): 34-44, 2023 Apr 07.
Artigo em Inglês | MEDLINE | ID: mdl-37390011

RESUMO

COVID-19 vaccination has resulted in decreased hospitalization and mortality, particularly among those who have received a booster. As new effective pharmaceutical treatments are now available and requirements for non-pharmaceutical interventions (e.g. masking) are relaxed, perceptions of the risk and health consequences of SARS-CoV-2 infection have decreased, risking potential resurgence. This June 2022 cross-sectional comparative study of representative samples in New York City (NYC, n = 2500) and the United States (US, n = 1000) aimed to assess differences in reported vaccine acceptance as well as attitudes toward vaccination mandates and new COVID-19 information and treatments. NYC respondents reported higher COVID-19 vaccine acceptance and support for vaccine mandate than U.S. respondents, yet lower acceptance for the booster dose. Nearly one-third of both NYC and U.S. respondents reported paying less attention to COVID-19 vaccine information than a year earlier, suggesting health communicators may need innovation and creativity to reach those with waning attention to COVID-19-related information.


Assuntos
Vacinas contra COVID-19 , COVID-19 , Humanos , Vacinas contra COVID-19/uso terapêutico , Cidade de Nova Iorque/epidemiologia , Estudos Transversais , COVID-19/epidemiologia , COVID-19/prevenção & controle , SARS-CoV-2 , Vacinação
4.
Am J Public Health ; 112(6): 931-936, 2022 06.
Artigo em Inglês | MEDLINE | ID: mdl-35420899

RESUMO

Objectives. To measure vaccine uptake and intentions among New York City (NYC) parents of children aged 5 to 11 years following emergency use authorization. Methods. We conducted a survey of 2506 NYC parents of children aged 5 to 11 years. We used survey weights to generate prevalence estimates of vaccine uptake and intentions. Multivariable Poisson regression models generated adjusted prevalence ratios (APRs) of vaccine hesitancy, defined as parents who reported being not very likely or not at all likely to vaccinate their children, or unsure about whether to do so. Results. Overall, 11.9% of NYC parents reported that their child was vaccinated; 51.0% were very or somewhat likely to vaccinate; 8.0% were not sure; 29.1% were not very likely or not at all likely to vaccinate their child. Among vaccine-hesitant parents, 89.9% reported safety concerns and 77.8% had concerns about effectiveness. In multivariable models, more vaccine hesitancy was expressed by non-Hispanic Black parents than by non-Hispanic White parents (APR = 1.41; 95% confidence interval [CI] = 1.17, 1.72) and by parents who were not themselves vaccinated than by parents who were vaccinated (APR = 1.53; 95% CI = 1.32, 1.77). Conclusions. In a survey conducted after authorization of COVID-19 vaccines for children aged 5 to 11 years, significant hesitancy among parents was observed. (Am J Public Health. 2022;112(6):931-936. https://doi.org/10.2105/AJPH.2022.306784).


Assuntos
COVID-19 , Vacinas , Vacinas contra COVID-19/uso terapêutico , Criança , Humanos , Cidade de Nova Iorque/epidemiologia , Pais , Vacinação
6.
J Health Commun ; 25(10): 838-842, 2020 Oct 02.
Artigo em Inglês | MEDLINE | ID: mdl-33719882

RESUMO

This paper describes the inception and evolution to date of CONVINCE - COVID-19 New Vaccine Information, Communication and Engagement - a rapidly expanding, voluntary global initiative to promote the use of effective public communications and engagement to build vaccine literacy and expedite immunization programs to protect communities against the COVID-19 Pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).


Assuntos
Vacinas contra COVID-19/uso terapêutico , COVID-19/prevenção & controle , Comunicação em Saúde , COVID-19/psicologia , Participação da Comunidade , Saúde Global , Comunicação em Saúde/métodos , Educação em Saúde/métodos , Letramento em Saúde , Humanos
7.
J Health Commun ; 25(10): 843-858, 2020 10 02.
Artigo em Inglês | MEDLINE | ID: mdl-33719890

RESUMO

In this bibliography, the researchers provide an introduction to the available evidence base of actions to promote vaccine literacy. The research team organized interventions to create a tool that can inform health communicators and practitioners seeking a resource focused on strategy and implementation design for actions that support vaccine literacy. This scoping bibliography is honed specifically to respond to the urgency of the current pandemic, when supporting and increasing vaccine literacy offers promise for achieving the critically needed high levels of vaccination. Over the course of the coming months and year, this bibliography will be a dynamic and "living" document hosted and maintained on vaccineliteracy.com.


Assuntos
Vacinas contra COVID-19 , Comunicação em Saúde , Letramento em Saúde , Humanos
8.
J Health Commun ; 25(10): 799-807, 2020 10 02.
Artigo em Inglês | MEDLINE | ID: mdl-33719881

RESUMO

In December 2020, the first COVID-19 vaccines were approved. Despite more than 85 million reported cases and 1.8 million known deaths, millions worldwide say they may not accept it. This study assesses the associations of age, gender, and level of education with vaccine acceptance, from a random sample of 13,426 participants selected from 19 high-COVID-19 burden countries in June 2020. Based on univariable and multivariable logistic regression, several noteworthy trends emerged: women in France, Germany, Russia, and Sweden were significantly more likely to accept a vaccine than men in these countries. Older (≥50) people in Canada, Poland, France, Germany, Sweden, and the UK were significantly more favorably disposed to vaccination than younger respondents, but the reverse trend held in China. Highly educated individuals in Ecuador, France, Germany, India, and the US reported that they will accept a vaccine, but higher education levels were associated with lower vaccination acceptance in Canada, Spain, and the UK. Heterogeneity by demographic factors in the respondents' willingness to accept a vaccine if recommended by employers were substantial when comparing responses from Brazil, Ecuador, France, India, Italy, Mexico, Poland, Russia, South Africa, South Korea, Sweden, and the US. This information should help public health authorities target vaccine promotion messages more effectively.


Assuntos
Vacinas contra COVID-19/uso terapêutico , COVID-19/prevenção & controle , Aceitação pelo Paciente de Cuidados de Saúde/estatística & dados numéricos , Fatores Etários , COVID-19/psicologia , Escolaridade , Feminino , Saúde Global/estatística & dados numéricos , Humanos , Masculino , Pessoa de Meia-Idade , Aceitação pelo Paciente de Cuidados de Saúde/psicologia , Fatores Sexuais , Inquéritos e Questionários
11.
J Health Commun ; 24(5): 581-583, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31262227

RESUMO

Immunization represents one of the greatest public health achievements. Vaccines save lives, make communities more productive and strengthen health systems. They are critical to attaining the UN Sustainable Development Goals. Vaccination also represents value for investment in public health. It is undisputedly one of the most cost-effective ways of avoiding disease, each year preventing 2-3 million deaths globally. We the concerned scientists, public health professionals, physicians, and child health advocates issue this Salzburg Statement along with the International Working Group on Vaccination and Public Health Solutions, proclaiming our unwavering commitment to universal childhood vaccination, and our pledge to support the development, testing, implementation, and evaluation of new, effective, and fact-based communication programs. Our goal is to explain vaccinations to parents or caregivers, answer their questions, address their concerns, and maintain public confidence in the personal, family and community protection that childhood vaccines provide. Every effort will also be made to communicate the dangers associated with these childhood illnesses to parents and communities since this information seems to have been lost in the present-day narrative. While vaccine misinformation has led to serious declines in community vaccination rates that require immediate attention, in other communities, particularly in low-income countries, issues such as lack of access. and unstable supply of vaccines need to be addressed.


Assuntos
Aceitação pelo Paciente de Cuidados de Saúde , Vacinação/psicologia , Vacinas/administração & dosagem , Cuidadores/educação , Cuidadores/psicologia , Criança , Comunicação , Humanos , Pais/educação , Pais/psicologia
19.
Nat Med ; 30(6): 1559-1563, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38684861

RESUMO

It is unclear how great a challenge pandemic and vaccine fatigue present to public health. We assessed perspectives on coronavirus disease 2019 (COVID-19) and routine immunization as well as trust in pandemic information sources and future pandemic preparedness in a survey of 23,000 adults in 23 countries in October 2023. The participants reported a lower intent to get a COVID-19 booster vaccine in 2023 (71.6%), compared with 2022 (87.9%). A total of 60.8% expressed being more willing to get vaccinated for diseases other than COVID-19 as a result of their experience during the pandemic, while 23.1% reported being less willing. Trust in 11 selected sources of vaccine information each averaged less than 7 on a 10-point scale with one's own doctor or nurse and the World Health Organization, averaging a 6.9 and 6.5, respectively. Our findings emphasize that vaccine hesitancy and trust challenges remain for public health practitioners, underscoring the need for targeted, culturally sensitive health communication strategies.


Assuntos
Vacinas contra COVID-19 , COVID-19 , Pandemias , SARS-CoV-2 , Confiança , Hesitação Vacinal , Humanos , COVID-19/prevenção & controle , COVID-19/epidemiologia , Adulto , Vacinas contra COVID-19/uso terapêutico , Masculino , Feminino , Pessoa de Meia-Idade , Pandemias/prevenção & controle , SARS-CoV-2/imunologia , Hesitação Vacinal/psicologia , Imunização , Inquéritos e Questionários , Vacinação/psicologia , Adulto Jovem , Idoso , Adolescente , Preparação para Pandemia , Fonte de Informação
20.
Vaccine ; 41(32): 4771-4776, 2023 07 19.
Artigo em Inglês | MEDLINE | ID: mdl-37357074

RESUMO

On 12 September 2022, attendees of the 16th Vaccine Congress in Riva del Garda, Italy were invited to attend a roundtable session entitled multi-sectoral actions to build trust at the local and community level to promote vaccine acceptance to participate in a discussion aimed at defining strategies and recommendations to support efforts that build community vaccine confidence. Presenters from the Vaccine Confidence Project and the New York Vaccine Literacy Campaign shared research and data point on the current state of vaccine confidence worldwide as well as global examples of "success stories" to prompt discussion. The group's key recommendations include prioritizing multi-sectoral responses and trust-building through policy and legislation, engaging with trusted local stakeholders, improving convenience, combating misinformation and empowering healthcare professionals to improve vaccine confidence. This report summarizes the considerations, recommendations, and suggested strategies discussed during the session, as prepared by the presenters.


Assuntos
Confiança , Vacinas , Humanos , Pessoal de Saúde , Comunicação , Políticas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA